HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
暂无分享,去创建一个
[1] K. Walton,et al. Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features. , 1983, Annals of the rheumatic diseases.
[2] G. Berríos,et al. Low and High Energy ECT , 1983, British Journal of Psychiatry.
[3] A. Vincent,et al. HLA antigens in penicillamine induced myasthenia gravis. , 1983, British medical journal.
[4] J. McCluskey,et al. Disease Associations with Complotypes, Supratypes and Haplotypes , 1983, Immunological reviews.
[5] C. Werning. [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.
[6] P. Kay,et al. The diagnostic significance of autoantibodies to the acetylcholine receptor. , 1982, Journal of neuroimmunology.
[7] A. Robin,et al. A Double-Blind Controlled Comparison of the Therapeutic Effects of Low and High Energy Electroconvulsive Therapies , 1982, British Journal of Psychiatry.
[8] A. Vincent,et al. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset. , 1982, Clinical and experimental immunology.
[9] M. Yaron,et al. Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. , 1982, Annals of the rheumatic diseases.
[10] P. Christensen,et al. EEG Monitored ECT , 1982, British Journal of Psychiatry.
[11] W. Coryell. Hypothalamic-pituitary-adrenal axis abnormality and ECT response , 1982, Psychiatry Research.
[12] D. Drachman,et al. Binding affinities of anti-acetylcholine receptor autoantibodies in myasthenia gravis. , 1982, Journal of immunology.
[13] J. Woodrow,et al. DR antigens and rheumatoid arthritis: a study of two populations. , 1981, British medical journal.
[14] R. Bucknall,et al. Cross‐reactivity of anti‐acetylcholine receptor autoantibodies , 1981, Muscle & nerve.
[15] M. J. Saunders,et al. Randomised controlled trial of rehabilitation in chronic respiratory disability. , 1981, Thorax.
[16] P. Zilko,et al. Myasthenia gravis and D-penicillamine. , 1981, The Journal of rheumatology. Supplement.
[17] J. Albers,et al. Penicillamine‐associated myasthenia gravis , 1980, Neurology.
[18] C. Dollery,et al. HYDRALAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS: INFLUENCE OF HLA-DR AND SEX ON SUSCEPTIBILITY , 1980, The Lancet.
[19] R. Griggs,et al. Penicillamine-induced myasthenia gravis in progressive systemic sclerosis. , 1980, Arthritis and rheumatism.
[20] C. Witt,et al. Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies. , 1979, Clinical immunology and immunopathology.
[21] J. Keesey,et al. HLA antigens in pencillamine‐induced myasthenia gravis , 1979, Neurology.
[22] A. Schuna,et al. Penicillamine-induced myasthenia gravis. , 1979, Arthritis and rheumatism.
[23] B. Maletzky. Seizure duration and clinical effect in electroconvulsive therapy. , 1978, Comprehensive psychiatry.
[24] J. Lindstrom,et al. Penicillamine‐induced myasthenia gravis associated with antibodies to acetylcholine receptor , 1978, Neurology.
[25] C. Masters,et al. Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies. , 1977, The American journal of medicine.
[26] R. Pirskanen,et al. ON THE SIGNIFICANCE OF HL‐A AND LD ANTIGENS IN MYASTHENIA GRAVIS * , 1976, Annals of the New York Academy of Sciences.
[27] L. Whitby. DEFINITIONS AND CRITERIA , 1974 .
[28] P. Timiras,et al. Stimulus intensity and duration of electroshock seizure response. , 1962, Experimental neurology.